Literature DB >> 9584198

The nucleic acid binding activity of bleomycin hydrolase is involved in bleomycin detoxification.

W Zheng1, S A Johnston.   

Abstract

Yeast bleomycin hydrolase, Gal6p, is a cysteine peptidase that detoxifies the anticancer drug bleomycin. Gal6p is a dual-function protein capable of both nucleic acid binding and peptide cleavage. We now demonstrate that Gal6p exhibits sequence-independent, high-affinity binding to single-stranded DNA, nicked double-stranded DNA, and RNA. A region of the protein that is involved in binding both RNA and DNA substrates is delineated. Immunolocalization reveals that the Gal6 protein is chiefly cytoplasmic and thus may be involved in binding cellular RNAs. Variant Gal6 proteins that fail to bind nucleic acid also exhibit reduced ability to protect cells from bleomycin toxicity, suggesting that the nucleic acid binding activity of Gal6p is important in bleomycin detoxification and may be involved in its normal biological functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584198      PMCID: PMC108939          DOI: 10.1128/MCB.18.6.3580

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

Review 1.  Polynucleotide recognition and degradation by bleomycin.

Authors:  S A Kane; S M Hecht
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1994

2.  The structure of trp RNA-binding attenuation protein.

Authors:  A A Antson; J Otridge; A M Brzozowski; E J Dodson; G G Dodson; K S Wilson; T M Smith; M Yang; T Kurecki; P Gollnick
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

3.  Alignment/phylogeny of the papain superfamily of cysteine proteases.

Authors:  P J Berti; A C Storer
Journal:  J Mol Biol       Date:  1995-02-17       Impact factor: 5.469

4.  Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease.

Authors:  J J Lin; D L Newton; S M Mikulski; H F Kung; R J Youle; S M Rybak
Journal:  Biochem Biophys Res Commun       Date:  1994-10-14       Impact factor: 3.575

5.  Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.

Authors:  Z Pei; T P Calmels; C E Creutz; S M Sebti
Journal:  Mol Pharmacol       Date:  1995-10       Impact factor: 4.436

6.  The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast.

Authors:  M M McA'Nulty; S J Lippard
Journal:  Mutat Res       Date:  1996-01-02       Impact factor: 2.433

7.  GAL4 interacts with TATA-binding protein and coactivators.

Authors:  K Melcher; S A Johnston
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

8.  Oxidative cell wall damage mediated by bleomycin-Fe(II) in Saccharomyces cerevisiae.

Authors:  S T Lim; C K Jue; C W Moore; P N Lipke
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

9.  Crystal structure of a conserved protease that binds DNA: the bleomycin hydrolase, Gal6.

Authors:  L Joshua-Tor; H E Xu; S A Johnston; D C Rees
Journal:  Science       Date:  1995-08-18       Impact factor: 47.728

10.  Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA.

Authors:  T S Krishna; X P Kong; S Gary; P M Burgers; J Kuriyan
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

View more
  5 in total

1.  Preferential localization of γH2AX foci in euchromatin of retina rod cells after DNA damage induction.

Authors:  Laura Lafon-Hughes; María Vittoria Di Tomaso; Pablo Liddle; Andrea Toledo; Ana Laura Reyes-Ábalos; Gustavo A Folle
Journal:  Chromosome Res       Date:  2013-12-10       Impact factor: 5.239

2.  Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein-chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure.

Authors:  S E Schaus; D Cavalieri; A G Myers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

3.  Induction of DNA double-strand breaks by zeocin in Chlamydomonas reinhardtii and the role of increased DNA double-strand breaks rejoining in the formation of an adaptive response.

Authors:  S G Chankova; E Dimova; M Dimitrova; P E Bryant
Journal:  Radiat Environ Biophys       Date:  2007-07-17       Impact factor: 1.925

Review 4.  Highlights in Resistance Mechanism Pathways for Combination Therapy.

Authors:  João M A Delou; Alana S O Souza; Leonel C M Souza; Helena L Borges
Journal:  Cells       Date:  2019-08-30       Impact factor: 6.600

5.  STAT3 imparts BRCAness by impairing homologous recombination repair in Epstein-Barr virus-transformed B lymphocytes.

Authors:  Michael T McIntosh; Siva Koganti; J Lucas Boatwright; Xiaofan Li; Salvatore V Spadaro; Alexis C Brantly; Jasmine B Ayers; Ramon D Perez; Eric M Burton; Sandeepta Burgula; Thomas MacCarthy; Sumita Bhaduri-McIntosh
Journal:  PLoS Pathog       Date:  2020-10-01       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.